These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 6190875)
21. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa. Mates A; Zand P J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979 [TBL] [Abstract][Full Text] [Related]
22. Sixth National Burn Seminar. Control of Pseudomonas infections by the immune processes. Feller I J Trauma; 1967 Jan; 7(1):93-5. PubMed ID: 6018140 [No Abstract] [Full Text] [Related]
23. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi. Roe EA; Jones RJ Rev Infect Dis; 1983; 5 Suppl 5():S922-30. PubMed ID: 6419315 [TBL] [Abstract][Full Text] [Related]
24. [Intravitreal injection of human anti-pseudomonas globulin in pseudomonas endophthalmitis in rabbits]. Hatano H; Tanaka N; Kawano M; Matsumoto K; Isobe Y; Inoue K Nippon Ganka Gakkai Zasshi; 1988 Dec; 92(12):2120-8. PubMed ID: 3266443 [No Abstract] [Full Text] [Related]
26. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization. Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420 [TBL] [Abstract][Full Text] [Related]
27. [Vaccination in pneumococcal and pseudomonas infections]. Liu BK Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Oct; 6(5):315-6. PubMed ID: 6676073 [No Abstract] [Full Text] [Related]
28. Symposium on infectious complications of neoplastic disease (Part II). Immunoprophylaxis and serotherapy of bacterial infections. Young LS Am J Med; 1984 Apr; 76(4):664-71. PubMed ID: 6424466 [TBL] [Abstract][Full Text] [Related]
29. Impact of molecular biology on Pseudomonas aeruginosa immunization. Pennington JE J Hosp Infect; 1988 Feb; 11 Suppl A():96-102. PubMed ID: 2896754 [TBL] [Abstract][Full Text] [Related]
30. Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum. Drake D; Montie TC Can J Microbiol; 1987 Sep; 33(9):755-63. PubMed ID: 3121159 [TBL] [Abstract][Full Text] [Related]
31. Oral vaccination and multivalent vaccine against Pseudomonas aeruginosa keratitis. Gerke JR; Nelson JS Invest Ophthalmol Vis Sci; 1977 Jan; 16(1):76-80. PubMed ID: 832968 [TBL] [Abstract][Full Text] [Related]
32. Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum. Ziegler EJ; McCutchan JA; Douglas H; Braude AI Trans Assoc Am Physicians; 1975; 88():101-8. PubMed ID: 772922 [TBL] [Abstract][Full Text] [Related]
33. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice. Moriyama K; Wiener-Kronish JP; Sawa T Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258 [TBL] [Abstract][Full Text] [Related]
34. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [TBL] [Abstract][Full Text] [Related]
35. Passive immunisation against Gram-negative bacilli in burns. Jones RJ Br J Exp Pathol; 1970 Feb; 51(1):53-8. PubMed ID: 4985031 [TBL] [Abstract][Full Text] [Related]
36. Systemic and topical protection studies using Pseudomonas aeruginosa flagella in an ocular model of infection. Rudner XL; Hazlett LD; Berk RS Curr Eye Res; 1992 Aug; 11(8):727-38. PubMed ID: 1424719 [TBL] [Abstract][Full Text] [Related]
37. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases. Kreger AS; Lyerly DM; Hazlett LD; Berk RS Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):932-9. PubMed ID: 3519522 [TBL] [Abstract][Full Text] [Related]